Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1985 2
1986 3
1987 3
1988 1
1989 2
1990 1
1994 1
1995 2
1996 2
1997 2
1998 1
1999 2
2000 1
2007 1
2008 1
2012 1
2014 1
2015 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

28 results
Results by year
Filters applied: . Clear all
Page 1
ACRIN 6665/RTOG 0132 phase II trial of neoadjuvant imatinib mesylate for operable malignant gastrointestinal stromal tumor: monitoring with 18F-FDG PET and correlation with genotype and GLUT4 expression.
Van den Abbeele AD, Gatsonis C, de Vries DJ, Melenevsky Y, Szot-Barnes A, Yap JT, Godwin AK, Rink L, Huang M, Blevins M, Sicks J, Eisenberg B, Siegel BA. Van den Abbeele AD, et al. Among authors: de vries dj. J Nucl Med. 2012 Apr;53(4):567-74. doi: 10.2967/jnumed.111.094425. Epub 2012 Mar 1. J Nucl Med. 2012. PMID: 22381410 Free PMC article. Clinical Trial.
Efficacy and safety of single-agent pertuzumab, a human epidermal receptor dimerization inhibitor, in patients with non small cell lung cancer.
Herbst RS, Davies AM, Natale RB, Dang TP, Schiller JH, Garland LL, Miller VA, Mendelson D, Van den Abbeele AD, Melenevsky Y, de Vries DJ, Eberhard DA, Lyons B, Lutzker SG, Johnson BE. Herbst RS, et al. Among authors: de vries dj. Clin Cancer Res. 2007 Oct 15;13(20):6175-81. doi: 10.1158/1078-0432.CCR-07-0460. Clin Cancer Res. 2007. PMID: 17947484 Free article. Clinical Trial.
28 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page